НовостиBenzingaUBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26 UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26 Benzinga 2026.10.12 13:40 (GMT+0) Открыть на Benzinga Другие новости